Research Groups and R&D Platforms: Antibodies, Assay development, Biomedicine, Cancer, Cardiovascular diseases, Clinical Chemistry, Drug delivery, Drug solubility, Drug stability, Formulation, Imaging, In Vivo Diagnostics, Infection, Inflammation, Medicinal chemistry, Metabolic diseases, Molecular diagnostics, Nanoparticles, Nucleic acids, Organic Chemistry, Organic compounds, Personalized medicine, PET, Pharmacy, Physico-chemical properties, Preclinical development, Synthetic chemistry
Research Group:
Radiopharmaceuticals for positron emission tomography (PET) imaging
Xiang-Guo Li
xiali[at]utu.fi
Turku PET Centre,
University of Turku
Antibodies, Assay development, Biomedicine, Cancer, Cardiovascular diseases, Clinical Chemistry, Drug delivery, Drug solubility, Drug stability, Formulation, Imaging, In Vivo Diagnostics, Infection, Inflammation, Medicinal chemistry, Metabolic diseases, Molecular diagnostics, Nanoparticles, Nucleic acids, Organic Chemistry, Organic compounds, Personalized medicine, PET, Pharmacy, Physico-chemical properties, Preclinical development, Synthetic chemistry
